3M™ Nexcare™ 432-50Recalls & reported problems

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00051131212787), received between Mar 11, 2019 and Nov 25, 2020 — classified as 3 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

• InjuryNov 25, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  A FEMALE CUSTOMER (AGE UNSPECIFIED) ALLEGED THE NEXCARE CLEAR WATERPROOF BANDAGES CAUSED RASH TO HER BACK (EXACT LOCATION UNSPECIFIED). THE CUSTOMER STATED SHE HAD A SURGICAL PROCEDURE DONE ON HER BACK ON (B)(6) 2020, AND SHE WAS INSTRUCTED BY THE DOCTOR TO CLEANSE THE SURGICAL AREA (CUSTOMER DID NOT SPECIFY WHAT WAS USED TO CLEAN AREA), APPLY VASELINE AND COVER WITH BANDAGE. THE CUSTOMER STATED SHE CHANGED THE BANDAGE EVERY NIGHT. THE CUSTOMER ALLEGED SHE NOTICED THE RASH 72 HOURS AFTER APPLYING THE BANDAGE. SHE STATED THE FIRST COUPLE OF DAYS SHE USED THE BANDAGE, SHE WASN'T SURE IF IT WAS THE BANDAGE THAT WAS IRRITATING HER OR IF IT WAS THE SURGICAL WOUND. THE CUSTOMER REPORTED SHE INSTRUCTED HER HUSBAND TO USE RUBBING ALCOHOL AND LOTION TO SOOTHE THE ALLEGED INJURY AREA. SHE ALLEGED THE RASH IS ABOUT 6 BY 6 INCHES BEYOND THE AREA WHERE THE BANDAGE TOUCHED HER SKIN. THE CUSTOMER ALLEGED THE DOCTOR PRESCRIBED MOMETASONE 1% FOR THE ALLEGED RASH. THE CUSTOMER REPORTED SHE'S ALLERGIC TO LATEX, CODEINE, IODINE AND SALSA RUGS. NO MEDICAL HISTORY REPORTED.

  Patient problems: Rash; Skin Inflammation/ Irritation

  MAUDE report 10905161 ↗
• InjuryJul 2, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  THE MOTHER OF A (B)(6) FEMALE REPORTED HER DAUGHTER APPLIED FOUR OF THE REFERENCED BANDAGES TO HER LEFT LEG, EACH APPLICATION, TO COVER A RASH ON THE INSIDE THIGH. SKIN PREPARATION DETAILS WERE NOT SPECIFIED. DATE(S) AND DURATION OF WEAR WAS NOT SPECIFIED. THE MOTHER REPORTED HER DAUGHTER CHANGED THE BANDAGES AFTER SHOWERING. TOTAL NUMBER OF APPLICATIONS WAS UNKNOWN. THE MOTHER ALLEGED HER DAUGHTER HAD A RED, BUMPY AND "BLISTERY" SKIN REACTION TO THE BANDAGES. THE REACTION OCCURRED WHERE THE BANDAGE ADHESIVE WAS IN CONTACT WITH THE SKIN. THE MOTHER REPORTED HER DAUGHTER HAS NO KNOWN ALLERGIES. THE DAUGHTER VISITED A DOCTOR ON APPROXIMATELY (B)(6) 2019. THE MOTHER REPORTED THE DOCTOR STATED HER DAUGHTER HAD A AN "ALLERGIC REACTION" TO THE BANDAGES. AN UNSPECIFIED TOPICAL MEDICATION WAS PRESCRIBED. THE DAUGHTER DISCONTINUED USE OF THE BANDAGES PER THE DOCTOR'S RECOMMENDATION. THE MOTHER REPORTED THE AFFECTED AREA WAS IMPROVING WITH THE USE OF THE PRESCRIBED MEDICATION.

  Patient problems: Erythema; Rash; Skin Irritation

  MAUDE report 8754458 ↗
• InjuryMar 11, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  A FEMALE CUSTOMER (AGE NOT SPECIFIED) APPLIED THE REFERENCED BANDAGES TO HER LEFT CHEEK TO COVER A SURGERY WOUND. THE WOMAN APPLIED THE BANDAGES TO COVER THE PARTIALLY HEALED WOUND WHILE GOING INTO WATER. THE BANDAGES WERE USED FOR A COUPLE OF WEEKS. BANDAGE ADHESIVE PLACEMENT WAS NOT ROTATED DURING APPLICATION. NO OINTMENT OR CREAMS WERE BEING APPLIED TO THE WOUND SITE. ON (B)(6) 2019, THE WOMAN ALLEGED NOTICING HER SKIN UNDERNEATH THE BANDAGE WAS BRIGHT RED UPON REMOVAL. SHE REPORTED THE BANDAGE WAS REMOVED GENTLY. THE REDDENED SKIN WAS REPORTED TO BE IN THE SHAPE OF THE BANDAGE ADHESIVE. NO BUMPS WERE PRESENT. NO KNOWN ALLERGIES WERE SPECIFIED. THE WOMAN DISCONTINUED USE OF THE BANDAGES. THE WOMAN ALLEGED THE SKIN SURROUNDING THE BANDAGE APPLICATION AREA DEVELOPED A BRIGHT RED RASH WHICH SPREAD. SHE CONSULTED A DERMATOLOGIST ON AN UNSPECIFIED DATE. THE DERMATOLOGIST RECOMMENDED HYDROCORTISONE 2.5% TOPICAL BE APPLIED OVER THE AFFECTED AREA. ON (B)(6) 2019, THE WOMAN REPORTED THE AFFECTED AREA WAS CLEARING UP WITH ONE DAY REMAINING ON PRESCRIBED HYDROCORTISONE.

  Patient problems: Erythema; Skin Irritation

  MAUDE report 8409476 ↗